Testing TQF3250 in healthy adults
Part of Hormones & metabolism clinical trials.
This trial tests a new oral medication (TQF3250) in healthy adults to see how safe it is and how the body processes it. If you are a generally healthy Chinese volunteer, you may be able to help researchers learn about this potential treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy Chinese adult between 18 and 55 years old.
- You are willing to use effective contraception (if you are a woman who could become pregnant) for 6 months after the study.
- Your weight is at least 50 kg (men) or 45 kg (women), and your BMI is between 20 and 40.
- You have no major medical conditions, and you are not taking any prescription or over-the-counter medications (including herbal supplements).
- You have not participated in another clinical trial or donated blood in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This phase 1 study tests a new medicine called YD0293 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This study tests a new capsule medicine for adults with type 2 diabetes who are overweight or have obesity. The goal is to see if it helps control blood sugar and weight.
This study tests a new experimental medication (QX-4533) in healthy volunteers to find the best dose and see how it works in the body. It involves taking the medication and having your health monitored closely over time.
This trial tests an experimental injection called TQF6422 for weight loss. It is an early-stage study in healthy overweight or obese adults to see how the drug affects the body and whether it is safe.
This trial tests a new pill called QX1206 for people who have both Type 2 diabetes and fatty liver disease (NAFLD). The goal is to see if the medicine is safe and can help improve both conditions.
Hear when a new Hyperglycemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.